Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

• Mehmet Serdar Küçükoğlu,
• İsmail Hanta,
• Bahri Akdeniz,
• Sümeyye Güllülü,
• Ersan Atahan,
• Tamer Sayın,
• Gülfer Okumuş,
• Zeynep Pınar Önen,
• Mehmet Yokuşoğlu,
• Arzu Baygül

Affiliations

Mehmet Serdar Küçükoğlu

Department of Cardiology, Istanbul University Cardiology Institute, Istanbul, Turkey

İsmail Hanta

Department of Chest Diseases, Cukurova University Faculty of Medicine, Adana, Turkey

Bahri Akdeniz

Department of Cardiology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

Sümeyye Güllülü

Department of Cardiology, Uludag University Faculty of Medicine, Bursa, Turkey

Ersan Atahan

Department of Chest Diseases, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul, Turkey

Tamer Sayın

Department of Cardiology, Ankara University Faculty of Medicine, Ankara, Turkey

Gülfer Okumuş

Department of Chest Diseases, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey

Zeynep Pınar Önen

Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Turkey

Mehmet Yokuşoğlu

Department of Cardiology, Gulhane Military Medical Academy, Ankara, Turkey

Arzu Baygül

Department of Biostatistics, Koc University School of Medicine, Istanbul, Turkey